Explore evidence

6 %Young (15–24 years) men comprised 6% of seroconverters in Eastern Uganda.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 16 observations

0.96 per_100_person_yearsHIV incidence rate was 0.96 per 100 person-years (95% CrI = 0.41–2.07, n = 10) after clinic reopening among gay, bisexual, and other men who have sex with men and transgender women in Kenya.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 6 observations

47.6 %Hospital microscopy had a sensitivity of 47.6% (95% CI = 38.2–57.1) and specificity of 86.7% (95% CI = 80.8–91.0) for malaria diagnosis in rural western Kenya from November 2019 through March 2020.

Kenyapaludismeobserved November 2019 through March 2020published 2022Malaria journalPubMeddocument of 15 observations

1.5 %Among 140 women with malaria in pregnancy at Webuye County Hospital in Western Kenya, 2 (1.5%) had gestational diabetes during pregnancy.

Kenyapaludismeobserved March 2022–December 2022published 2024BMC pregnancy and childbirthPubMeddocument of 9 observations

64.1 %Observed HIV prevalence among inherited widowed women was 64.1% (95% CI: 63.2–65.4%).

KenyaVIH/sidapublished 2025BMC medicinePubMeddocument of 2 observations

5 %Among 606 girls aged 10–14 years in informal settlements of Nairobi, Kenya, 5% experienced sexual violence in the past 6 months.

Kenyasexual violenceobserved past 6 monthspublished 2020PloS onePubMeddocument of 11 observations

51.25 odds_ratioMalaria was associated with very low birth weight with an odds ratio of 51.250 among neonates born at Thika Level Five Hospital in Kiambu County, Kenya, during July–August 2019.

Kenyafaible poids de naissance · paludismeobserved July–August 2019published 2023International Journal of Health SciencesOpenAlexdocument of 7 observationsDOI 10.47941/ijhs.1464

1.3 %The prevalence of group B streptococcus (GBS) was 1.3% during the late first trimester.

Kenyagroup B streptococcus (GBS)published 2026PloS onePubMeddocument of 4 observations

32 %During the last 3 months of the trial, 32% of family planning clients were tested for HIV at control clinics in Mombasa, Kenya.

KenyaVIH/sidapublished 2022AIDS (London, England)europe_pmcdocument of 3 observations

0 seroconversionsNo HIV seroconversions were observed over the follow-up period.

KenyaVIH/sidapublished 2023JAMA network openPubMeddocument of 9 observations

8.5 %In Nairobi, breast cancer incidence rates stabilized during 2010 to 2014 after rapidly increasing from 2003 to 2010, with an annual percent change of 8.5% (95% CI: 3.0–14.2).

Kenyacancer du seinobserved 2010 to 2014published 2020International journal of cancereurope_pmcdocument of 4 observations

19 %19% of women living with HIV agreed with at least three internalized stigma statements, indicating medium/high levels of internalized stigma.

KenyaVIH/sidaobserved 2015 to 2017published 2021BMC women's healthPubMeddocument of 7 observations

1.56 aHRDepot medroxyprogesterone acetate (DMPA) was significantly associated with elevated risk of HIV seroconversion in women with bacterial vaginosis (adjusted hazard ratio 1.56, 95% confidence interval 1.08–2.25).

Kenyavaginose bactérienne · VIH/sidaobserved 1993 to 2017published 2019AIDS (London, England)europe_pmcdocument of 4 observationsDOI 10.1097/qad.0000000000002167

The 501Y.V2 variant of concern circulated locally in the Comoros Islands during the country’s first major SARS-CoV-2 wave in January 2021.

Kenya501Y.V2 variant of concern · COVID-19observed January 2021published 2021Detection of SARS-CoV-2 variant 501Y.V2 in Comoros Islands in January 2021europe_pmcDOI 10.1101/2021.04.08.21254321

2,257 individualsFrom October 2022 to December 2023, 2257 individuals were screened and 1915 were enrolled in the ePrEP Kenya pilot.

KenyaVIH/sidaobserved October 2022 to December 2023published 2025Journal of the International AIDS SocietyPubMeddocument of 19 observations

68 %Most (68%) of snake bite cases among a rural population in Kenya sought treatment from a traditional healer.

Kenyasnake bitepublished 1994Annals of tropical medicine and parasitologyeurope_pmcdocument of 5 observations

21.4 %Patients with confirmed severe malaria had a significantly increased cumulative incidence of discharge by 21.4%.

Kenyapaludismepublished 2022BMJ openPubMeddocument of 9 observations

95 %hrHPV testing at 12 months for recurrent CIN2+ had 95% negative predictive value.

KenyahrHPV · lésions précancéreuses du col (CIN)observed 12 monthspublished 2021JAMA oncologyPubMeddocument of 16 observations

6 samplesSix SARS-CoV-2 positive samples were genome sequenced from the first major infection wave in the Union of Comoros in January 2021.

KenyaCOVID-19observed January 2021published 2021Wellcome open researcheurope_pmcdocument of 3 observations

1,500,000,000 peopleSoil-transmitted helminths infect 1.5 billion people in developing countries.

Kenyasoil-transmitted helminthspublished 2016BMC infectious diseaseseurope_pmcdocument of 6 observations

0.3 hazard_ratioThe hazard ratio for hospital readmission or death in the dihydroartemisinin-piperaquine chemoprevention group compared to the placebo group was 0.30 (95% CI, 0.22 to 0.42) during the intervention period (week 3 through week 14).

Kenyasevere anemiapublished 2020The New England journal of medicinePubMeddocument of 5 observations

1.1 %Trajectory modeling identified that 1.1% of women living with HIV had persistent moderate-to-severe depressive symptoms throughout the peripartum period.

Kenyadepressive symptomspublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

84.5 %Sputum smear microscopy (SSM) recorded a positive predictive value of 84.5% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobserved 2022-2023published 2024PloS onePubMeddocument of 7 observations

0 infectionsThere were no incident HIV infections in 400 person-years of follow-up in the intervention group.

KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 9 observations

96 %Of 25 participants with incident HIV infection, 24/25 (96%) started antiretroviral therapy (ART).

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations